Filtering by:
LeukemiaFDA Approves Mylotarg (Gemtuzumab Ozogamicin) for Acute Myeloid Leukemia
The US Food and Drug Administration (FDA) has approved Mylotarg (gemtuzumab ozogamicin) for adults and children with certain types of acute myeloid leukemia (AML).
FDA Approves Besponsa (Inotuzumab Ozogamicin) for Acute Lymphoblastic Leukemia in Adults
The US Food and Drug Administration has approved the targeted therapy drug Besponsa (inotuzumab ozogamicin) for adults with B-cell precursor acute lymphoblastic leukemia (ALL) that is not getting better with treatment, or came back after treatment.
Leukemia Survivor: ‘Every Day is a Day of Hope’
Barbara Borrell’s health problems began the day she was born in 1942 when she was diagnosed with diabetes. For the next 50 years she made nutrition and exercise a priority. But in 1993, she was diagnosed with chronic lymphocytic leukemia.
FDA Approves Rydapt (Midostaurin) for Acute Myeloid Leukemia
The US Food and Drug Administration (FDA) has approved the first targeted therapy to treat adults with acute myeloid leukemia (AML).